Phase IV

Phase IV clinical trials

Phase IV trials are normally conducted in order to build data on the long-term safety and efficacy of compounds which have marketing approval, or to provide technical support for an approved therapy. Actelion’s strategy is to maximize the value created with its products by providing additional evidence in specific patient groups to assist physicians in their treatment approach.

 
 

Actelion's phase IV portfolio:

PhaseProduct/ CompoundIndicationStudyResults expected
IVBosentanCombination bosentan and sildenafil in PAHCOMPASS-2-
IVMiglustatType 1 Gaucher disease patients switched from ERT to miglustatMAINTENANCE2010

 
 

Top of page    Print pageSend this page to a friendBookmark with del.icio.usBookmark with diggBookmark with MISTER WONG

 
 
 
 
 

Administrative Assistant, US 

 

"We can make a difference for patients with life threatening illnesses."